All Stories

  1. Are specialized sperm function tests clinically useful in planning assisted reproductive technology?
  2. An update on clinical and surgical interventions to reduce sperm DNA fragmentation in infertile men
  3. Extended indications for sperm retrieval: summary of current literature
  4. Oocyte quantity, as well as oocyte quality, plays a significant role for the cumulative live birth rate of a POSEIDON criteria patient
  5. The POSEIDON Criteria and Its Measure of Success Through the Eyes of Clinicians and Embryologists
  6. Clinical utility of freeze-all approach in ART treatment: A mini-review
  7. Fresh versus frozen blastocyst transfer
  8. Management Strategies for POSEIDON Groups 3 and 4
  9. Social Media in the Urology Practice | Opinion: YES
  10. Future Perspectives of POSEIDON Stratification for Clinical Practice and Research
  11. Management of Women With an Unexpected Low Ovarian Response to Gonadotropin
  12. Clinical utility of sperm DNA damage in male infertility
  13. Hot topics in male infertility: an afterword
  14. Indications and outcomes of varicocele repair
  15. Male infertility and assisted reproductive technology
  16. Methods of surgical sperm extraction and implications for assisted reproductive technology success
  17. Paternal age and assisted reproductive technology: problem solver or trouble maker?
  18. Testicular sperm for intracytoplasmic sperm injection in non-azoospermic men: a paradigm shift
  19. Correction to: The role of recombinant LH in women with hypo-response to controlled ovarian stimulation: a systematic review and meta-analysis
  20. A Novel Predictive Model to Estimate the Number of Mature Oocytes Required for Obtaining at Least One Euploid Blastocyst for Transfer in Couples Undergoing in vitro Fertilization/Intracytoplasmic Sperm Injection: The ART Calculator
  21. Hormonal stimulation of spermatogenesis: a new way to treat the infertile male with non-obstructive azoospermia?
  22. The role of recombinant LH in women with hypo-response to controlled ovarian stimulation: a systematic review and meta-analysis
  23. The relationship among sperm global DNA methylation, telomere length, and DNA fragmentation in varicocele: a cross-sectional study of 20 cases
  24. A quality management approach to controlled ovarian stimulation in assisted reproductive technology: the "Fischer protocol"
  25. Estimation of age-dependent decrease in blastocyst euploidy by next generation sequencing: development of a novel prediction model
  26. Female infertility and assisted reproductive technology
  27. Freeze-all strategy in IVF/ICSI cycles: an update on clinical utility
  28. Hot topics in female infertility: an afterword
  29. Impact of Body Mass Index on female fertility and ART outcomes
  30. Interventions to Prevent Sperm DNA Damage Effects on Reproduction
  31. Male Oxidative Stress Infertility (MOSI): Proposed Terminology and Clinical Practice Guidelines for Management of Idiopathic Male Infertility
  32. Novel approaches for diagnosis and management of low prognosis patients in assisted reproductive technology: the POSEIDON concept
  33. Pharmacogenetic algorithm for individualized controlled ovarian stimulation in assisted reproductive technology cycles
  34. Protein supplementation intake for bodybuilding and resistance training may impact sperm quality of subfertile men undergoing fertility treatment: a pilot study
  35. Fresh versus elective frozen embryo transfer in IVF/ICSI cycles: a systematic review and meta-analysis of reproductive outcomes
  36. Storage of sperm samples from males with azoospermia
  37. Reactive oxygen species-induced alterations in H19-Igf2 methylation patterns, seminal plasma metabolites, and semen quality
  38. Understanding Ovarian Hypo-Response to Exogenous Gonadotropin in Ovarian Stimulation and Its New Proposed Marker—The Follicle-To-Oocyte (FOI) Index
  39. Defining Low Prognosis Patients Undergoing Assisted Reproductive Technology: POSEIDON Criteria—The Why
  40. Testicular versus ejaculated sperm should be used for intracytoplasmic sperm injection (ICSI) in cases of infertility associated with sperm DNA fragmentation | Opinion: Yes
  41. Proteomic Signatures of Sperm Mitochondria in Varicocele: Clinical Use as Biomarkers of Varicocele Associated Infertility
  42. Intracytoplasmic sperm injection for male infertility and consequences for offspring
  43. Clinical relevance of genetic variants of gonadotrophins and their receptors in controlled ovarian stimulation: a systematic review and meta-analysis
  44. The ‘Big Freeze’: freeze-all should not be used for everyone
  45. Use of testicular sperm in nonazoospermic males
  46. Should a Couple with Failed In Vitro Fertilization or Intracytoplasmic Sperm Injection and Elevated Sperm DNA Fragmentation Use Testicular Sperm for the Next Cycle?
  47. Association Between Progesterone Elevation on the Day of Human Chronic Gonadotropin Trigger and Pregnancy Outcomes After Fresh Embryo Transfer in In Vitro Fertilization/Intracytoplasmic Sperm Injection Cycles
  48. Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review
  49. Effect of varicocele repair on sperm DNA fragmentation: a review
  50. Individualized controlled ovarian stimulation in expected poor-responders: an update
  51. Poor definition of poor-ovarian response results in misleading clinical recommendations
  52. Human sperm handling in intracytoplasmic sperm injection processes: In vitro studies on mouse oocyte activation, embryo development competence and sperm oxidation-reduction potential
  53. Use of Testicular Sperm for ICSI: Pro
  54. Response: Nitroblue tetrazolium (NBT) assay
  55. Use of testicular sperm for intracytoplasmic sperm injection in men with high sperm DNA fragmentation: a SWOT analysis
  56. Faculty of 1000 evaluation for Review: Diagnosis and impact of sperm DNA alterations in assisted reproduction.
  57. Association between promoter methylation of MLH1 and MSH2 and reactive oxygen species in oligozoospermic men-A pilot study
  58. REPLY BY THE AUTHORS: Re: Persistent Mullerian Duct Syndrome: a rare entity with a rare presentation in need of multidisciplinary management
  59. Reproductive outcomes of testicular versus ejaculated sperm for intracytoplasmic sperm injection among men with high levels of DNA fragmentation in semen: systematic review and meta-analysis
  60. A Strengths-Weaknesses-Opportunities-Threats (SWOT) analysis on the clinical utility of sperm DNA fragmentation testing in specific male infertility scenarios
  61. A single cut-off value of sperm DNA fragmentation testing does not fit all
  62. All-round approach in diagnosis
  63. An evidence-based perspective on the role of sperm chromatin integrity and sperm DNA fragmentation testing in male infertility
  64. Antioxidants for elevated sperm DNA fragmentation: a mini review
  65. Best practice statements are not intended to dictate an exclusive course of management
  66. Call for wider application of sperm DNA fragmentation test
  67. Clinical utility of sperm DNA fragmentation testing: concise practice recommendations
  68. Comparison of strategies to reduce sperm DNA fragmentation in couples undergoing ICSI
  69. Current limitation and future perspective of sperm DNA fragmentation tests
  70. Despite limitations, sperm DNA fragmentation testing provides unique information complementary to but distinct from semen analysis results
  71. Development of targeted therapeutic strategies and refinement of sperm DNA fragmentation testing
  72. Development of treatment strategies in men with vulnerable sperm
  73. Drawbacks of the current practice
  74. Elucidating the clinical indications of sperm DNA fragmentation in male infertility
  75. Expanding our understanding of clinical laboratory testing in male infertility patients
  76. Expanding treatment paradigm of high sperm DNA fragmentation
  77. From bench to clinic
  78. Frontiers in clinical andrology
  79. Further evidence supports the clinical utility of sperm DNA fragmentation testing in male infertility workup and assisted reproductive technology
  80. Future direction in sperm DNA fragmentation testing
  81. Implication of sperm processing during assisted reproduction on sperm DNA integrity
  82. Insights on the predictive accuracy of the sperm DNA fragmentation tests on male infertility
  83. Integrating surgical and clinical andrology is essential to improve the quality of care delivered to infertile couples
  84. Is National Institute of Clinical Excellence (NICE) guideline a nice guideline?
  85. It is high time for clinical application of sperm DNA fragmentation testing
  86. Live birth must be the primary reproductive endpoint in IVF/ICSI studies evaluating sperm DNA fragmentation testing
  87. More good than harm should be expected when Testi-ICSI is applied to oligozoospermic men with post-testicular sperm DNA fragmentation
  88. One of the many missing links between infertility and sperm DNA fragmentation
  89. Reactive oxygen species and sperm DNA fragmentation
  90. Restoration of fertility potential via targeted treatment approach
  91. Risk factors associated with sperm DNA fragmentation
  92. Sperm DNA fragmentation for the evaluation of male infertility: clinical algorithms
  93. Sperm DNA fragmentation in clinical practice
  94. Sperm DNA fragmentation test results reflect the overall quality of the whole semen specimen
  95. Sperm DNA fragmentation testing in patients with subclinical varicocele: is there any evidence?
  96. Sperm DNA fragmentation testing is on the right track
  97. Sperm DNA fragmentation testing is the safe and economical way to go
  98. Sperm DNA fragmentation testing reveals the overall quality of a semen sample
  99. Sperm DNA fragmentation testing: a cross sectional survey on current practices of fertility specialists
  100. Sperm DNA fragmentation: a key player in decision making
  101. Sperm DNA fragmentation: a rationale for its clinical utility
  102. Sperm DNA fragmentation: laboratory and clinical aspects
  103. Sperm DNA fragmentation: overcoming standardization obstacles
  104. Technical aspects of sperm DNA fragmentation testing, methods to select sperm with low DNA fragmentation, and usefulness of redox potential measurement in male infertility
  105. The Society for Translational Medicine: clinical practice guidelines for sperm DNA fragmentation testing in male infertility
  106. The complex nature of the sperm DNA damage process
  107. The correct interpretation of sperm DNA fragmentation test
  108. The debate on sperm DNA fragmentation test goes on
  109. The importance of quality control and quality assurance in SDF testing
  110. The missing piece in management of infertile couple—clinical andrology
  111. The price and value of sperm DNA fragmentation tests
  112. The problem of mixing ‘apples and oranges’ in meta-analytic studies
  113. The role of female factors in the management of sperm DNA fragmentation
  114. The value of sperm DNA fragmentation testing in real-life clinical presentations
  115. Understanding sperm DNA fragmentation
  116. Unraveling the utility and limitations of clinical practice guidelines
  117. Use of sperm DNA fragmentation testing and testicular sperm for intracytoplasmic sperm injection
  118. Editorial Comment: Antioxidant enzyme profile and lipid peroxidation products in semen samples of testicular germ cell tumor patients submitted to orchiectomy
  119. GnRH Agonist Trigger and LH Activity Luteal Phase Support versus hCG Trigger and Conventional Luteal Phase Support in Fresh Embryo Transfer IVF/ICSI Cycles—A Systematic PRISMA Review and Meta-analysis
  120. Multi-centre assessment of nitroblue tetrazolium reactivity in human semen as a potential marker of oxidative stress
  121. Ascorbic acid reduces redox potential in human spermatozoa subjected to heat-induced oxidative stress
  122. Oxidative Stress in Human Reproduction
  123. Reply to Eugenio Ventimiglia, Montorsi Francesco, and Andrea Salonia's Letter to the Editor re: Reecha Sharma, Avi Harlev, Ashok Agarwal, Sandro C. Esteves. Cigarette Smoking and Semen Quality: A New Meta-analysis Examining the Effect of the 2010 World...
  124. POSEIDON’s stratification of ‘Low prognosis patients in ART”: The WHY, the WHAT, and the HOW
  125. Clinical utility of sperm DNA fragmentation testing: practice recommendations based on clinical scenarios
  126. Persistent Mullerian Duct Syndrome: a rare entity with a rare presentation in need of multidisciplinary management
  127. Clean Room Technology in ART Clinics
  128. Management of Infertile Men with Nonobstructive Azoospermia due to Spermatogenic Failure
  129. Reply from Authors re: Christian Leiber, Ulrich Wetterauer. The Cigarette and the Sperm: A Fatal Liaison? Eur Urol 2016;70:646–7
  130. Cigarette Smoking and Semen Quality: A New Meta-analysis Examining the Effect of the 2010 World Health Organization Laboratory Methods for the Examination of Human Semen
  131. A missing vas deferens: practical implications for urologists performing vasectomies and managing infertile men
  132. Abstinence Time and Its Impact on Basic and Advanced Semen Parameters
  133. Author Reply
  134. Novel concepts in male factor infertility: clinical and laboratory perspectives
  135. Should we evaluate and treat sperm DNA fragmentation?
  136. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept
  137. Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay using bench top flow cytometer for evaluation of sperm DNA fragmentation in fertility laboratories: protocol, reference values, and quality control
  138. Outcome of assisted reproductive technology in men with treated and untreated varicocele: systematic review and meta-analysis
  139. A systematic review of clinical practice guidelines and best practice statements for the diagnosis and management of varicocele in children and adolescents
  140. Outcome of varicocele repair in men with nonobstructive azoospermia: systematic review and meta-analysis
  141. Novel insights into the pathophysiology of varicocele and its association with reactive oxygen species and sperm DNA fragmentation
  142. Bibliometrics: tracking research impact by selecting the appropriate metrics
  143. Effect of varicocele on semen characteristics according to the new 2010 World Health Organization criteria: a systematic review and meta-analysis
  144. Summary evidence on the effects of varicocele treatment to improve natural fertility in subfertile men
  145. Specialized sperm function tests in varicocele and the future of andrology laboratory
  146. Varicocele and male infertility: current concepts and future perspectives
  147. Afterword to varicocele and male infertility: current concepts and future perspectives
  148. Implementation of cleanroom technology in reproductive laboratories: the question is not why but how
  149. Air quality control in the ART laboratory is a major determinant of IVF success
  150. Establishing a quality management system in a fertility center: experience with ISO 9001
  151. Varicocele and Male Infertility
  152. Association Between Varicocele and Infertility
  153. Cost-Effectiveness of Varicocele Treatment
  154. Definitions and Epidemiology
  155. Effect of Varicocele Treatment
  156. Guidelines and Best Practice Statements for the Evaluation and Management of Infertile Adult and Adolescent Males with Varicocele
  157. Origin and Pathophysiology
  158. Subclinical Varicocele
  159. Treatment Modalities
  160. Varicocele Classification
  161. Varicocele and Azoospermia
  162. Varicocele in Adolescents
  163. Comparison of reproductive outcome in oligozoospermic men with high sperm DNA fragmentation undergoing intracytoplasmic sperm injection with ejaculated and testicular sperm
  164. Pregnancy and birth after intracytoplasmic sperm injection with normal testicular spermatozoa in a patient with azoospermia and tail stump epididymal sperm
  165. A systematic review of recent clinical practice guidelines and best practice statements for the evaluation of the infertile male
  166. Percutaneous epididymal sperm aspiration as a method for sperm retrieval in men with obstructive azoospermia seeking fertility: operative and laboratory aspects
  167. Diagnostic accuracy of sperm DNA degradation index (DDSi) as a potential noninvasive biomarker to identify men with varicocele-associated infertility
  168. RE: Clinical relevance of routine semen analysis and controversies surrounding the 2010 World Health Organization criteria for semen examination
  169. Clinical management of infertile men with nonobstructive azoospermia
  170. Cervical Hostility and Vaginal pH in Females with Unexplained Infertility
  171. Controversies Surrounding the 2010 World Health Organization Cutoff Values for Human Semen Characteristics and Its Impact on Unexplained Infertility
  172. Definitions and Relevance of Unexplained Infertility in Reproductive Medicine
  173. Efficacy, efficiency and effectiveness of gonadotropin therapy for infertility treatment
  174. Genetic Basis of Unexplained Male Infertility
  175. Gonadotropin in Assisted Reproduction: An Evolution Perspective
  176. Impact of Mutations and Polymorphisms of Gonadotrophins and Their Receptors on the Outcome of Controlled Ovarian Stimulation
  177. Insights into the role of cervical mucus and vaginal pH in unexplained infertility
  178. List of Contributors
  179. Unexplained Infertility
  180. Role and Significance of Sperm Function in Men with Unexplained Infertility
  181. Sperm Physiology and Assessment of Spermatogenesis Kinetics In Vivo
  182. The Role of LH in Controlled Ovarian Stimulation
  183. Engaging Practicing Gynecologists in the Management of Infertile Men
  184. Effect of mobile telephones on sperm quality: A systematic review and meta-analysis
  185. Clinical relevance of routine semen analysis and controversies surrounding the 2010 World Health Organization criteria for semen examination
  186. A translational medicine appraisal of specialized andrology testing in unexplained male infertility
  187. Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech
  188. Diagnostic accuracy of sperm chromatin dispersion test to evaluate sperm deoxyribonucleic acid damage in men with unexplained infertility
  189. Chapter-06 Male Infertility: When and How to Start the Evaluation?
  190. Shedding Light on the Controversy Surrounding the Temporal Decline in Human Sperm Counts: A Systematic Review
  191. Effectiveness of sperm washing by discontinuous density gradient centrifugation to remove antibodies bound to the sperm membrane
  192. Comparison of sperm retrieval and reproductive outcome in azoospermic men with testicular failure and obstructive azoospermia treated for infertility
  193. Re: Sperm retrieval rates and intracytoplasmic sperm injection outcomes for men with non-obstructive azoospermia and the health of resulting offspring
  194. Microdissection Testicular Sperm Extraction (micro-TESE) as a Sperm Acquisition Method for Men with Nonobstructive Azoospermia Seeking Fertility: Operative and Laboratory Aspects
  195. Characterisation of a subpopulation of sperm with massive nuclear damage, as recognised with the sperm chromatin dispersion test
  196. Hypogonadotropic Hypogonadism Revisited
  197. A comprehensive review of genetics and genetic testing in azoospermia
  198. An update on sperm retrieval techniques for azoospermic males
  199. Predictive factors for sperm retrieval and sperm injection outcomes in obstructive azoospermia: Do etiology, retrieval techniques and gamete source play a role?
  200. Reproductive outcomes, including neonatal data, following sperm injection in men with obstructive and nonobstructive azoospermia: case series and systematic review
  201. The azoospermic male: current knowledge and future perspectives
  202. PESA/TESA/TESE Sperm Processing
  203. Quality Management in ART Clinics
  204. Varicocele
  205. Surgical Treatment for Male Infertility
  206. Implementation of air quality control in reproductive laboratories in full compliance with the Brazilian Cells and Germinative Tissue Directive
  207. Reproductive Potential of Men with Obstructive Azoospermia Undergoing Percutaneous Sperm Retrieval and Intracytoplasmic Sperm Injection According to the Cause of Obstruction
  208. A clinical appraisal of the genetic basis in unexplained male infertility
  209. Micro-dissection testicular sperm extraction as an alternative for sperm acquisition in the most difficult cases of Azoospermia: Technique and preliminary results in India
  210. Insight into oxidative stress in varicocele-associated male infertility: part 2
  211. Insight into oxidative stress in varicocele-associated male infertility: part 1
  212. Brazil
  213. Defining What Reproductive Laboratories Do
  214. Ensuring that Reproductive Laboratories Provide High-Quality Services
  215. Explaining How Reproductive Laboratories Work
  216. Introduction to Quality Management in ART Clinics
  217. The Role of Reproductive Laboratories in the ART Clinic
  218. Unexplained Male infertility: diagnosis and Management
  219. Editorial Comment
  220. What every gynecologist should know about male infertility: an update
  221. Varicocele
  222. Surgical Treatment for Male Infertility
  223. Evaluation and Diagnosis of Male Infertility
  224. Surgical Management of Male Infertility
  225. PESA/TESA/TESE Sperm Processing
  226. Chapter-05 Semen Preparation: Ejaculated Sperm for ICSI
  227. Chapter-06 Semen Preparation: Sperm Extraction for ICSI
  228. A Critical Appraisal on the Role of Varicocele in Male Infertility
  229. Critical Appraisal of World Health Organization's New Reference Values for Human Semen Characteristics and Effect on Diagnosis and Treatment of Subfertile Men
  230. Laboratory handling of epididymal and testicular spermatozoa: What can be done to improve sperm injections outcome
  231. Sperm retrieval techniques for assisted reproduction
  232. Impact of the New WHO Guidelines on Diagnosis and Practice of Male Infertility
  233. What is New in the Clinical Assessment and Treatment of the Infertile Male
  234. Relationship of in Vitro Acrosome Reaction to Sperm Function: An Update
  235. Male Infertility and Assisted Reproductive Technology: Lessons from the IVF
  236. Unexplained male infertility
  237. Chromosomal and molecular abnormalities in a group of Brazilian infertile men with severe oligozoospermia or non-obstructive azoospermia attending an infertility service
  238. Sperm retrieval techniques
  239. Novel concepts in male infertility
  240. An update on the clinical assessment of the infertile male
  241. Surgical treatment of male infertility in the era of intracytoplasmic sperm injection - new insights
  242. Clinical Outcome of Intracytoplasmic Sperm Injection in Infertile Men With Treated and Untreated Clinical Varicocele
  243. Editorial Comment
  244. A comparison of menotropin, highly-purified menotropin and follitropin alfa in cycles of intracytoplasmic sperm injection
  245. Editorial Comment
  246. Resistance of human spermatozoa to cryoinjury in repeated cycles of thaw-refreezing
  247. Re: sperm defect severity rather than sperm source is associated with lower fertilization rates after intracytoplasmic sperm injection
  248. Sperm defect severity rather than sperm source is associated with lower fertilization rates after intracytoplasmic sperm injection
  249. Influence of antisperm antibodies in the semen on intracytoplasmic sperm injection outcome
  250. Effects of pentoxifylline treatment before freezing on motility, viability and acrosome status of poor quality human spermatozoa cryopreserved by the liquid nitrogen vapor method
  251. Evaluation of acrosomal status and sperm viability in fresh and cryopreserved specimens by the use of fluorescent peanut agglutinin lectin in conjunction with hypo-osmotic swelling test
  252. Recovery of spermatogenesis after microsurgical subinguinal varicocele repair in azoospermic men based on testicular histology
  253. Feasibility of refreezing human spermatozoa through the technique of liquid nitrogen vapor
  254. Intracytoplasmic sperm injection: optical magnification during sperm selection and microinjection affects fertilization, cleavage, and pregnancy rates
  255. Effects of semen thaw-refreeze by standard vapor freezing method on human sperm motility, viability and morphology
  256. Sperm kinematics of normozoospermic specimens after stimulation by varying concentrations of a specific inhibitor of CGMP phosphodiesterase type-5 (Sildenafil)
  257. Effects of the technique of cryopreservation and dilution/centrifugation after thawing on the motility and vitality of spermatozoa of oligoasthenozoospermic men
  258. Improvement in motion characteristics and acrosome status in cryopreserved human spermatozoa by swim-up processing before freezing
  259. RECOVERY OF SPERMATOGENESIS AFTER MICROSURGICAL VARICOCELE REPAIR IN AZOOSPERMIC MEN IS RELATED TO TESTICULAR HISTOLOGY
  260. Cryopreservation of human spermatozoa with pentoxifylline improves the post-thaw agonist-induced acrosome reaction rate
  261. TRANSURETHRAL RESECTION OF PARTIALLY OBSTRUCTED EJACULATORY DUCTS
  262. TRANSURETHRAL RESECTION OF PARTIALLY OBSTRUCTED EJACULATORY DUCTS: SEMINAL PARAMETERS AND PREGNANCY OUTCOMES ACCORDING TO THE ETIOLOGY OF OBSTRUCTION
  263. Ureteroscopic Stone Removal in the Distal Ureter. Why Change?
  264. Ureteroscopic Stone Removal in the Distal Ureter. Why Change?
  265. Laparoscopic Pediatric Orchiectomy
  266. Comparative Study of the Fertility Potential of Men with only one Testis